This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Agios Pharmaceuticals, Inc., Celgene Corporation. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 99 
2 out of 561 
Years Active: 2020
Title: The Innovations of Robert Douglas Knight
Introduction
Robert Douglas Knight is a notable inventor based in Berkeley Heights, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 2 patents, Knight's work focuses on combination therapies for malignancies, particularly in patients with specific genetic mutations.
Latest Patents
Knight's latest patents include methods and compositions for treating cancers in patients carrying an IDH2 mutation. This involves using a combination of an inhibitor of a mutant IDH2 enzyme and a DNA demethylating agent. Additionally, he has developed a combination therapy for treating hematological malignancies in patients with an IDH1 mutation. This therapy utilizes an inhibitor of the mutant IDH1 enzyme along with a DNA demethylating agent.
Career Highlights
Throughout his career, Knight has worked with prominent companies in the pharmaceutical industry, including Celgene Corporation and Agios Pharmaceuticals, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in cancer therapies.
Collaborations
Knight has collaborated with several professionals in his field, including Vivek Saroj Kumar Chopra and Jorge DiMartino. These collaborations have further enhanced his research and innovation efforts.
Conclusion
Robert Douglas Knight's contributions to cancer treatment through his innovative patents demonstrate his commitment to advancing medical science. His work continues to impact the lives of patients facing malignancies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile